TECON BIOLOGY Co.LTD (002100.SZ)
CNY 6.7
(0.0%)
CNY 6.7
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.75 Billion | 327.98 Million | 1.53 Billion | -600.85 Million | 306.97 Million | -1.17 Billion |
| Net Income | -1.51 Billion | 214.14 Million | -678.51 Million | 1.78 Billion | 592.39 Million | 301.05 Million |
| Depreciation & Amortization | 802.91 Million | 713.19 Million | 704.94 Million | 448.1 Million | 316.79 Million | 213.26 Million |
| Deferred income taxes | -23.08 Million | -14.8 Million | -6.46 Million | -1.74 Million | 556.32 Thousand | -1.69 Million |
| Stock-based compensation | - | - | - | 19.18 Million | - | - |
| Change in working capital | 1.62 Billion | -1.05 Billion | 794.84 Million | -3.11 Billion | -806.92 Million | -1.79 Billion |
| Other non-cash items | 256.65 Million | 457.33 Million | 711.68 Million | 262.22 Million | 204.71 Million | 105.52 Million |
| Investing Cash Flow | -774.99 Million | -2.07 Billion | -1.77 Billion | -806.41 Million | -1.36 Billion | -789.1 Million |
| Investments in PPE | -1 Billion | -1.43 Billion | -1.75 Billion | -929.74 Million | -1.35 Billion | -593.05 Million |
| Acquisitions | -359.18 Million | -31.55 Million | -23.88 Million | -468.34 Thousand | -111.2 Million | 5.73 Million |
| Investment purchases | -117 Million | -650 Million | 3.35 Million | -5.48 Million | -1.94 Million | -5.69 Million |
| Sales/Maturities of investments | 754.1 Million | 17.57 Million | 4.3 Million | - | 1.43 Million | 9.65 Million |
| Other Investing Activities | -52.47 Million | 21.65 Million | -6.63 Million | 129.28 Million | 102.56 Million | -205.74 Million |
| Financing Cash Flow | -1.5 Billion | 1.63 Billion | 1.6 Billion | 1.5 Billion | 933.32 Million | 2.25 Billion |
| Debt repayment | -966.46 Million | -4.73 Billion | -5.61 Billion | -3.46 Billion | -3 Billion | -1.34 Billion |
| Dividends payments | -298.01 Million | -260.85 Million | -494.78 Million | -212.37 Million | -99.88 Million | -151.84 Million |
| Common Stock Repurchased | - | - | - | - | -10 Million | -30 Million |
| Common Stock Issuance | - | - | - | - | 10 Million | - |
| Other Financing Activities | 53 Million | 6.63 Billion | 7.91 Billion | 5.37 Billion | 4.19 Billion | 3.74 Billion |
| Accounts receivables | 855.47 Million | -528.52 Million | 759.92 Million | -1.08 Billion | -484.75 Million | -144.26 Million |
| Accounts payables | -65.2 Million | 35.03 Million | -98.63 Million | 896.02 Million | 272.71 Million | -51.6 Million |
| Inventory | 861.25 Million | -548.38 Million | 139.63 Million | -2.92 Billion | -595.44 Million | -1.6 Billion |
| Other working capital | 53.2 Million | -14.8 Million | -6.07 Million | -1.74 Million | 556.32 Thousand | -197.56 Million |
| Cash at beginning of period | 3.2 Billion | 3.31 Billion | 1.95 Billion | 1.85 Billion | 1.97 Billion | 1.69 Billion |
| Cash at end of period | 2.67 Billion | 3.2 Billion | 3.31 Billion | 1.95 Billion | 1.85 Billion | 1.97 Billion |
| Capital Expenditure | -1 Billion | -1.43 Billion | -1.75 Billion | -929.74 Million | -1.35 Billion | -593.05 Million |
| Effect of forex changes on cash | - | 1.00 | - | -0.58 | 1.94 | -0.07 |
| Net cash flow / Change in cash | -528.37 Million | -110.82 Million | 1.36 Billion | 92.79 Million | -121.63 Million | 283.22 Million |
| Free Cash Flow | 750.48 Million | -1.1 Billion | -219.37 Million | -1.53 Billion | -1.04 Billion | -1.77 Billion |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 288.94 Million | 222.61 Million | 54.06 Million | -858.93 Million | -1.51 Billion | -57.09 Million |
| Depreciation & Amortization | - | 235.72 Million | 235.72 Million | 130.03 Million | 802.91 Million | -545.45 Million |
| Deferred income taxes | - | - | - | - | -23.08 Million | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | 256.85 Million | - | 1.76 Billion | 1.62 Billion | -1.31 Billion |
| Other non-cash items | 1.08 Billion | 1.12 Billion | -387.91 Million | -554.12 Million | 256.65 Million | 3.66 Billion |
| Investing Cash Flow | -40.65 Million | -324.86 Million | -187.47 Million | -347.31 Million | -774.99 Million | -131.72 Million |
| Investments in PPE | -31.87 Million | -300.59 Million | -201.27 Million | -279.2 Million | -1 Billion | -266.53 Million |
| Acquisitions | - | 31.53 Million | - | 17 Million | -359.18 Million | 10.45 Million |
| Investment purchases | 31.54 Million | -31.54 Million | - | -313.16 Million | -117 Million | 100 Million |
| Sales/Maturities of investments | -21.03 Million | 21.03 Million | - | 104.1 Million | 754.1 Million | -110.44 Million |
| Other Investing Activities | -8.77 Million | -24.3 Million | 13.79 Million | -73.05 Million | -52.47 Million | 134.8 Million |
| Financing Cash Flow | -552.59 Million | -627.31 Million | 397.01 Million | 818.66 Million | -1.5 Billion | -1.57 Billion |
| Debt repayment | -510.18 Million | -575.59 Million | -443.53 Million | -846.56 Million | -966.46 Million | -2.06 Billion |
| Dividends payments | -42.41 Million | -48.94 Million | -46.51 Million | -298.01 Million | -298.01 Million | -74.34 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | -83.22 Million | -46.51 Million | -3 Million | 53 Million | 565.61 Million |
| Accounts receivables | - | -377.32 Million | - | 855.47 Million | 855.47 Million | -402.72 Million |
| Accounts payables | - | - | - | - | -65.2 Million | - |
| Inventory | - | 634.17 Million | - | 861.25 Million | 861.25 Million | -915.95 Million |
| Other working capital | - | - | - | 53.2 Million | 53.2 Million | - |
| Cash at beginning of period | 2.7 Billion | 2.54 Billion | 2.67 Billion | 3.74 Billion | 3.2 Billion | 3.71 Billion |
| Cash at end of period | 3.48 Billion | 2.7 Billion | 2.54 Billion | 2.67 Billion | 2.67 Billion | 3.74 Billion |
| Capital Expenditure | -31.87 Million | -300.59 Million | -201.27 Million | -279.2 Million | -1 Billion | -266.53 Million |
| Effect of forex changes on cash | - | - | - | - | - | -0.07 |
| Net cash flow / Change in cash | 778.87 Million | 155 Million | -124.31 Million | -1.07 Billion | -528.37 Million | 34.88 Million |
| Free Cash Flow | 1.34 Billion | 806.59 Million | -535.12 Million | -1.82 Billion | 750.48 Million | 1.47 Billion |
ACSAY
BAJEL
SEL
SDIIF
ZNC
WINVR